Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 22:9:737854.
doi: 10.3389/fmed.2022.737854. eCollection 2022.

Emergence of Lyme Disease on the French Riviera, a Retrospective Survey

Affiliations

Emergence of Lyme Disease on the French Riviera, a Retrospective Survey

Jacques Sevestre et al. Front Med (Lausanne). .

Abstract

Background: The French Riviera has been declared free of Lyme Borreliosis (LB) for years. Many patients are referred for presumed LB, sometimes with atypical clinical signs and/or doubtful serology, calling the diagnosis into question.

Methods: Patients were assessed for LB diagnosis, depending on clinical presentation, laboratory findings, and further examination by other medical professionals.

Results: Among 255 patients, 45 (18%) were classified as confirmed LB cases [including 28 ongoing LB (10%) and 17 past LB (8%)], and for 210 (82%) a Lyme borreliosis diagnosis was ruled out. Among ongoing LB, 56% had been exposed to or bitten by ticks, exclusively in rural locations of the Alpes-Maritimes. As a result of the diagnostic procedure, 132 (52%) patients had been treated. An alternative diagnosis was established for 134 (52%) patients, covering a wide range of conditions, including mainly psychological (28%) and neurological conditions (25%) or inflammatory and systemic diseases (22%).

Conclusions: Our results strongly suggest the endemicity of LB in the Alpes-Maritimes region. Confirmed LB accounted for 18% of patients while 52% were diagnosed with other conditions.

Keywords: Borrelia; French Riviera; Ixodes ricinus; Lyme; borreliosis.

PubMed Disclaimer

Conflict of interest statement

CM was employed by company SYNLAB Barla GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Nelson CA, Saha S, Kugeler KJ, Delorey MJ, Shankar MB, Hinckley AF, et al. . Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010. Emerg Infect Dis. (2015) 21:1625–31. 10.3201/eid2109.150417 - DOI - PMC - PubMed
    1. Stanek G, Strle F. Lyme Disease, European Perspective. Infect Dis Clin North Am. (2008) 22:327–39. 10.1016/j.idc.2008.01.001 - DOI - PubMed
    1. Robert AS, Phoebe M. An estimate of Lyme borreliosis incidence in Western Europe. Journal of Public Health. (2017) 39:74–81. 10.1093/pubmed/fdw017 - DOI - PubMed
    1. Figoni J, Chirouze C, Hansmann Y, Lemogne C, Hentgen V, Saunier A, et al. . Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis. Médecine Mal Infect. (2019) 49:318–34. 10.1016/j.medmal.2019.04.381 - DOI - PubMed
    1. Chirio D, Queyrel V, Gonfrier G, Fuzibet JG. Une maladie de Lyme azuréenne. Rev Médecine Interne. (2016) 37:A189–90. 10.1016/j.revmed.2016.04.197 - DOI